Role of astrocytic glycolytic metabolism in Alzheimer’s disease pathogenesis

Biogerontology

Volumn 15, Issue 6, 2014, Pages 579-586

  Fu, Wen ^a   Jhamandas, Jack H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aging; Alzheimer s disease; Amyloid; Astrocyte; Glycolysis

Indexed keywords

AMYLOID PROTEIN; GLUCOSE;

AGING; ALZHEIMER DISEASE; ASTROCYTE; ASTROCYTOSIS; CYTOKINE RELEASE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; REVIEW; AGED; BRAIN; METABOLISM; METABOLOME; RISK FACTOR;

AGED; AGING; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; GLUCOSE; GLYCOLYSIS; HUMANS; METABOLOME; NEURONS; RISK FACTORS;

EID: 84916604479     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-014-9525-0     Document Type: Review

References (74)

1. Allaman I, Gavillet M, Bélanger M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30(9):3326–3338. doi:10.1523/JNEUROSCI.5098-09.2010
2. Almeida A, Moncada S, Bolaños JP (2004) Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6(1):45–51
3. Almeida A, Bolaños JP, Moreno S (2005) Cdh1/Hct1-APC is essential for the survival of postmitotic neurons. J Neurosci 25(36):8115–8121
4. Ames A III, Maynard KI, Kaplan S (1995) Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J Cereb Blood Flow Metab 15(3):433–439
5. Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21(10):1133–1145
6. Bando H, Atsumi T, Nishio T, Niwa H, Mishima S, Shimizu C, Yoshioka N, Bucala R, Koike T (2005) Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin Cancer Res 11(16):5784–5792
7. Barres BA (2008) The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60(3):430–440. doi:10.1016/j.neuron.2008.10.013
8. Bauernfeind AL, Barks SK, Duka T, Grossman LI, Hof PR, Sherwood CC (2014) Aerobic glycolysis in the primate brain: reconsidering the implications for growth and maintenance. Brain Struct Funct 219(4):1149–1167. doi:10.1007/s00429-013-0662-z
9. Bélanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte- neuron metabolic cooperation. Cell Metab 14:724–738
10. Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ, Sell C, Torres C (2012) Astrocyte senescence as a component of Alzheimer’s disease. PLoS ONE 7(9):e45069. doi:10.1371/journal.pone.0045069
11. Bigl M, Brückner MK, Arendt T, Bigl V, Eschrich K (1999) Activities of key glycolytic enzymes in the brains of patients with Alzheimer’s disease. J Neural Transm 106(5–6):499–511
12. Bolaños JP, Almeida A, Moncada S (2010) Glycolysis: a bioenergetic or a survival pathway? Trends Biochem Sci 35(3):145–149. doi:10.1016/j.tibs.2009.10.006
13. Breuer ME, Koopman WJ, Koene S, Nooteboom M, Rodenburg RJ, Willems PH, Smeitink JA (2013) mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiol Dis 51:27–34. doi:10.1016/j.nbd.2012.03.007
14. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, Starkey MP (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer’s disease. Brain Res 1127(1):127–135
15. Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B (2009) Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage. J Neurosci Res 87(11):2484–2497. doi:10.1002/jnr.22074
16. Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, LaFerla FM, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX (2012) Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer’s disease. PLoS ONE 7(12):e51432. doi:10.1371/journal.pone.0051432
17. Cotrina ML, Nedergaard M (2002) Astrocytes in the aging brain. J Neurosci Res 67:1–10
18. de la Torre JC (2011) Three postulates to help identify the cause of Alzheimer’s disease. J Alzheimers Dis 24(4):657–668. doi:10.3233/JAD-2011-101884
19. Demetrius LA, Driver J (2013) Alzheimer’s as a metabolic disease. Biogerontology 14(6):641–649. doi:10.1007/s10522-013-9479-7
20. Demetrius LA, Simon DK (2012) An inverse-Warburg effect and the origin of Alzheimer’s disease. Biogerontology 13(6):583–594. doi:10.1007/s10522-012-9403-6
21. Dienel GA (2012) Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab 32:1107–1138
22. Ding F, Yao J, Rettberg JR, Chen S, Brinton RD (2013) Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer’s mouse brain: implication for bioenergetic intervention. PLoS ONE 8(11):e79977. doi:10.1371/journal.pone.0079977
23. Drachman DA (2006) Aging of the brain, entropy, and Alzheimer disease. Neurology 67(8):1340–1352
24. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-31 years (1969–2000). Neurochem Res 25(9–10):1439–1451
25. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer’s disease. Curr Drug Targets 11(10):1193–1206
26. García-Higuera I, Manchado E, Dubus P, Cañamero M, Méndez J, Moreno S, Malumbres M (2008) Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 10(7):802–811. doi:10.1038/ncb1742
27. Goss JR, Finch CE, Morgan DG (1991) Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging 12:165–170
28. Goyal MS, Hawrylycz M, Miller JA, Snyder AZ, Raichle ME (2014) Aerobic glycolysis in the human brain is associated with development and neotenous gene expression. Cell Metab 19(1):49–57. doi:10.1016/j.cmet.2013.11.020
29. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356
30. Hasemann CA, Istvan ES, Uyeda K, Deisenhofer J (1996) The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies. Structure 4(9):1017–1029
31. Hayakawa N, Kato H, Araki T (2007) Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector. Mech Ageing Dev 128:311–316
32. Heneka MT, Rodriguez JJ, Verkhratsky A (2010) Neuroglia in neurodegeneration. Brain Res Rev 63:189–211
33. Kohama SG, Goss JR, Finch CE, McNeill TH (1995) Increases of glial fibrillary acidic protein in the aging female mouse brain. Neurobiol Aging 16:59–67
34. Lee YH, Li Y, Uyeda K, Hasemann CA (2003) Tissue-specific structure/function differentiation of the liver isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J Biol Chem 278(1):523–530
35. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA (2008) Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 105(11):4441–4446. doi:10.1073/pnas.0709259105
36. Lucin KM, Wyss-Coray T (2009) Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64(1):110–122. doi:10.1016/j.neuron.2009.08.039
37. Maestre C, Delgado-Esteban M, Gomez-Sanchez JC, Bolaños JP, Almeida A (2008) Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J 27(20):2736–2745. doi:10.1038/emboj.2008.195
38. Magistretti PJ (2006) Neuron-glia metabolic coupling and plasticity. J Exp Biol 209(Pt 12):2304–2311
39. Marsin AS, Bouzin C, Bertrand L, Hue L (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6- phosphofructo-2-kinase. J Biol Chem 277(34):30778–30783
40. Mohamed A, Posse de Chaves E (2011) Aβ internalization by neurons and glia. Int J Alzheimers Dis 2011:127984. doi:10.4061/2011/127984
41. Nichols NR, Day JR, Laping NJ, Johnson SA, Finch CE (1993) GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14:421–429
42. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S (2009) Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57(9):978–988. doi:10.1002/glia.20822
43. Novellasdemunt L, Bultot L, Manzano A, Ventura F, Rosa JL, Vertommen D, Rider MH, Navarro-Sabate À, Bartrons R (2013) PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli. Biochem J 452(3):531–543. doi:10.1042/BJ20121886
44. Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29(10):547–553
45. Okamura N, Sakakibara R (1998) A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase. Biosci Biotechnol Biochem 62(10):2039–2042
46. Okar DA, Manzano A, Navarro-Sabatè A, Riera L, Bartrons R, Lange AJ (2001) PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26(1):30–35
47. Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab 32:1152–1166
48. Pesin JA, Orr-Weaver TL (2008) Regulation of APC/C activators in mitosis and meiosis. Annu Rev Cell Dev Biol 24:475–499. doi:10.1146/annurev.cellbio.041408.115949
49. Pfeiffer T, Schuster S, Bonhoeffer S (2001) Cooperation and competition in the evolution of ATP-producing pathways. Science 292:504–507
50. Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344
51. Rossi D, Volterra A (2009) Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 80(4–5):224–232. doi:10.1016/j.brainresbull.2009.07.012
52. Salminen A, Ojala J, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H (2011) Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci 34(1):3–11. doi:10.1111/j.1460-9568.2011.07738.x
53. Schönfeld P, Reiser G (2013) Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab 33(10):1493–1499. doi:10.1038/jcbfm.2013.128
54. Selfridge JE, Lu J, Swerdlow RH (2013) Role of mitochondrial homeostasis and dynamics in Alzheimer’s disease. Neurobiol Dis 51:3–12. doi:10.1016/j.nbd.2011.12.057
55. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. doi:10.1101/cshperspect.a006189
56. Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151–170
57. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119(1):7–35. doi:10.1007/s00401-009-0619-8
58. Stegmüller J, Bonni A (2005) Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons. Trends Neurosci 28(11):596–601
59. Stobart JL, Anderson CM (2013) Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front Cell Neurosci 7:38. doi:10.3389/fncel.2013.00038
60. Swerdlow RH (2007) Is aging part of Alzheimer’s disease, or is Alzheimer’s disease part of aging? Neurobiol Aging 28(10):1465–1480
61. Tang F, Lane S, Korsak A, Paton JF, Gourine AV, Kasparov S, Teschemacher AG (2014) Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 5:3284. doi:10.1038/ncomms4284
62. Tanzi RE (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2(10):a006296. doi:10.1101/cshperspect.a006296
63. Tomi M, Zhao Y, Thamotharan S, Shin BC, Devaskar SU (2013) Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer’s disease with aging. Brain Res 1495:61–75
64. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033. doi:10.1126/science.1160809
65. Verkhratsky A, Parpura V (2010) Recent advances in (patho) physiology of astroglia. Acta Pharmacol Sin 31(9):1044–1054. doi:10.1038/aps.2010.108
66. Verkhratsky A, Toescu EC (2006) Neuronal-glial networks as substrate for CNS integration. J Cell Mol Med 10(4):869–879
67. Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M (2012) Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 4(3):e00082. doi:10.1042/AN20120010
68. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA (2010) Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci USA 107(41):17763–17767. doi:10.1073/pnas.1010461107
69. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6(8):626–640
70. Wang DD, Bordey A (2008) The astrocyte odyssey. Prog Neurobiol 86(4):342–367. doi:10.1016/j.pneurobio.2008.09.015
71. Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B (2011) In vivo evidence for lactate as a neuronal energy source. J Neurosci 31(20):7477–7485. doi:10.1523/JNEUROSCI.0415-11.2011
72. Yankner BA, Lu T, Loerch P (2008) The aging brain. Annu Rev Pathol 3:41–66
73. Yao J, Rettberg JR, Klosinski LP, Cadenas E, Brinton RD (2011) Shift in brain metabolism in late onset Alzheimer’s disease: implications for biomarkers and therapeutic interventions. Mol Aspects Med 32(4–6):247–257. doi:10.1016/j.mam.2011.10.005
74. Yun SW, Hoyer S (2000) Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer’s disease? J Neural Transm 107(3):355–368